548. Baseline characteristics associated with clinical improvement and mortality in hospitalized patients with moderate COVID-19
BACKGROUND: Remdesivir (RDV) has been shown to shorten recovery time and was well tolerated in patients with severe COVID-19. Here we report baseline characteristics associated with clinical improvement at day (d) 14. METHODS: We enrolled hospitalized patients with confirmed SARS-CoV-2 infection, ox...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778131/ http://dx.doi.org/10.1093/ofid/ofaa439.742 |